Identification of a novel breast-cancer-
β
Lambert C.J. Dorssers; Jos Veldscholte
π
Article
π
1997
π
John Wiley and Sons
π
French
β 177 KB
π 2 views
Development of anti-estrogen resistance limits the benefit of endocrine therapy of breast cancer. The mechanistic basis for resistance to the anti-estrogen tamoxifen may involve (epi)genetic alterations within tumor cells. We have initiated a random search for genes allowing estrogen-dependent ZR-75